Clinigma is a leading brand that brings exceptional value to pharmaceutical companies by serving as the structured voice of their trial patients. In line with the FDA's Patient-Focused initiatives, Clinigma excels in capturing patient feedback in clinical trials. They offer a range of services to support clients in patient-focused drug development, including expert solutions in gathering critical insights from patients and caregivers.

By incorporating direct patient-experience feedback into medical product development, Clinigma is revolutionizing the way drugs are developed, used, and valued, while minimizing uncertainties in drug development and approvals. What sets Clinigma apart is their exclusive specialization in interviewing clinical trial patients to capture and analyze patient-experience data. With a worldwide network of over 200 qualitative researchers, they can conduct interviews in more than 70 languages and offer in-person interviews in almost any country.

Additionally, Clinigma has developed a unique IT portal that simplifies the patient interview process, ensuring easy and secure collection of patient-experience data and facilitating seamless communication between the research team, clients, clinical sites, and trial participants. Clinigma is ISO 9001:2015 certified for designing, conducting, analyzing, and reporting patient interviews related to clinical trials. By choosing Clinigma, pharmaceutical companies can meet the increasing expectations for comprehensive patient-experience data in clinical trials and contribute to the advancement of medical product development.

Join the community committed to amplifying the voices of patients and contact Clinigma today